Closing the Men's Health Gap: Why At-Home Hormone Testing Should Be in Every Health Plan's Playbook

Every June, Men's Health Month prompts a familiar conversation: men don't go to the doctor. They delay, avoid, and rationalize until something goes wrong. For public health advocates, this is a behavioral challenge. For health plans, it's a quality metric problem and it shows up in HEDIS scores, Star Ratings, and chronic disease management costs across the board.

The numbers are stark. On average, American men live roughly six years less than women, and experience disproportionately higher mortality rates across nine of the ten leading causes of death. Research consistently shows that men are less likely than women to receive preventive services like blood pressure screening, cholesterol testing, and routine checkups — even when coverage is available. One large-scale analysis found that women comprised 56.4% of primary care patients across all age groups, a gap that persists even controlling for morbidity burden.³

For Medicare Advantage plans and digital health companies, this engagement gap isn't just a clinical problem. It's a financial and operational one. Hard-to-reach male members accumulate undetected risk — and untreated risk becomes high-cost intervention. Closing the gap starts with meeting men where they actually are: at home.

Why Don’t Men Seek Care?

The barriers to male healthcare engagement are well-documented. Qualitative research points to a cluster of cultural factors: equating care-seeking with weakness, discomfort with clinical settings, skepticism about the value of preventive testing, and general friction with the scheduling and logistics of in-person care. These aren't barriers that clinic recall programs solve on their own. A letter asking a member to schedule a blood draw doesn't overcome years of avoidance.

What does reduce friction is a pathway that removes the need to come in at all.

The Male Hormone Panel: What It Covers and Why It Matters

Hormonal health is often at the center of male members' undetected risk. Testosterone levels decline gradually with age — and the clinical consequences compound over time. The HIM Study, one of the largest prevalence studies to date, found that 38.7% of men aged 45 and older presenting to primary care offices were hypogonadal. National survey data suggests that approximately 13.8 million American men aged 45 and older may have low testosterone — with a prevalence of testosterone deficiency reaching 25.7% across the broader male population.

Left unaddressed, low testosterone is associated with decreased muscle mass, impaired bone density, metabolic syndrome, and elevated cardiovascular risk. It also frequently co-occurs with conditions health plans are already tracking: obesity, type 2 diabetes, and depression.

A comprehensive at-home male hormone panel — which can include testosterone, PSA (prostate-specific antigen), cortisol, estradiol, and other key biomarkers — gives health plans and their digital health partners a meaningful window into a member's hormonal baseline. Unlike a single testosterone test kit, which captures one data point, a full panel provides the clinical context needed to prioritize follow-up and connect members with appropriate care.

For a deeper look at what each biomarker in Ash's hormone panels measures and why, see our recent post: At-Home Testing: What Health Plans Should Know About Thyroid, Testosterone & Cortisol Panels.

How At-Home Hormone Testing Fits Into a Health Plan's Engagement Strategy

The strategic value of at-home hormone testing for health plans goes beyond the clinical data it produces. It's an activation tool — a way to create a positive touchpoint with the segment of your membership least likely to engage through traditional channels.

Here's how it works in practice. A member receives a branded, white-labeled kit that includes everything needed for a self-collection blood spot sample: clear instructions, a prepaid return label, and support via email or SMS if they have questions. The sample goes to a CLIA-certified lab. Results are reviewed by a licensed clinician before delivery. If values fall outside reference ranges, the member is connected to appropriate next steps — including referral to their in-network primary care provider.

The entire experience happens without a clinic appointment, without a copay friction point, and without requiring the member to voluntarily seek care. That's the essential shift: instead of waiting for male members to act, you're delivering a reason to engage directly to their door.

Our at-home gap closure programs are designed to do exactly this at scale — with bilingual outreach in English and Spanish, multi-channel member engagement across IVR, email, and SMS, and a fully white-labeled member experience that carries your plan's brand, not ours.

Members who receive Ash's multi-channel outreach complete testing 2.4× more often than with single-channel methods — which translates directly into more closed care gaps, not just higher open rates.

What Health Plans and Digital Health Companies Should Do Now

Men's Health Month is a natural moment for health plan communications teams to activate male-specific messaging — but the operational infrastructure needs to be in place before the campaign launches. A few things to consider:

Identify the gap in your data. How do your male members' preventive screening completion rates compare to female members'? How many men in your 45–75 age cohort haven't had a recent blood draw or hormone screen? That gap is your addressable population.

Pair hormonal testing with measures you're already tracking. Cortisol imbalances compound diabetes risk. Low testosterone correlates with metabolic syndrome. A hormone panel isn't an isolated clinical program — it's a window into the chronic conditions already on your quality dashboard.

Plan for the follow-up, not just the kit. At-home testing is only as valuable as the care pathway that follows an abnormal result. Ash's programs capture member PCP information and route results through clinician review so that follow-up is built into the workflow, not bolted on.

For health plans looking to close the men's health gap this summer, at-home hormone testing for men is one of the highest-leverage, lowest-friction places to start.

Ready to build a program? Contact Ash to learn how we support health plans and digital health companies with customized at-home testing programs across 100+ biomarkers in all 50 states.

‍